SlideShare a Scribd company logo
1 of 166
ENZYMES
 Enzymes are proteins that help speed up
chemical reactions in our bodies. Enzymes
are essential for digestion, liver function and
much more. Too much or too little of a certain
enzyme can cause health problems.
Enzymes in our blood can also help
healthcare providers check for injuries and
diseases.
 What are enzymes?
 Enzymes are proteins that help speed up
metabolism, or the chemical reactions in our
bodies. They build some substances and
break others down. All living things have
enzymes.
 Our bodies naturally produce enzymes. But
enzymes are also manufactured .
 What do enzymes do?
 One of the most important roles of
enzymes is to aid in digestion. Digestion
is the process of turning the food we eat
into energy. For example, there are
enzymes in our saliva, pancreas,
intestines and stomach.
 They break down fats, proteins and
carbohydrates. Enzymes use these nutrients
for growth and cell repair.
 Enzymes also help with:
 Breathing.
 Building muscle.
 Nerve function.
 Ridding our bodies of toxins.
 What are the different types of enzymes?
 There are thousands of individual enzymes in
the body. Each type of enzyme only has one
job. For example, the enzyme sucrase
breaks down a sugar called sucrose. Lactase
breaks down lactose, a kind of sugar found in
milk products.
 Some of the most common digestive
enzymes are:
 Carbohydrase breaks down
carbohydrates into sugars.
 Lipase breaks down fats into fatty acids.
 Protease breaks down protein into amino
acids.
 What are the parts of an enzyme?
 Each enzyme has an “active site.” This area
has a unique shape. The substance an
enzyme works on is a substrate. The
substrate also has a unique shape. The
enzyme and the substrate must fit together
to work.
 How do temperature and pH affect enzymes?
 Enzymes need the right conditions to work. If
conditions aren’t right, enzymes can change
shape. Then, they no longer fit with
substrates, so they don’t work correctly.
 Each enzyme has an ideal temperature
and pH:
 pH: Enzymes are sensitive to acidity and
alkalinity. They don’t work properly if an
environment is too acidic or basic. For
example, an enzyme in the stomach
called pepsin breaks down proteins. If
your stomach doesn’t have enough acid,
pepsin can’t function optimally.
 Temperature: Enzymes work best when
your body temperature is normal, about
(37°C). As temperature increases,
enzyme reactions increase. But if the
temperature gets too high, the enzyme
stops working. That’s why a
high fever can disrupt bodily functions.
 How are enzyme tests used to diagnose
health conditions?
 Your healthcare provider can use a variety
of enzyme and protein blood tests to check
for certain health conditions. For
example, elevated liver enzymes could be a
sign of liver disease.
ENZYMES
DEFINITION: they are the catalysts of
biological system, colloidal,
thermolabile & protein in nature.
erm Meaning
Catalyst
A substance that speeds up a
chemical reaction without
being changed
Enzyme
A biological catalyst (usually
a protein)
Substrate
The reactant molecule that
an enzyme works on
Active site
The part of the enzyme where
the substrate binds
 Enzymes: How they work and what
they do
 The part of the enzyme where the
substrate binds is called the active site.
Here, the enzyme changes shape slightly,
fitting tightly with the substrate and
forming the enzyme/substrate complex.
 Enzymes help speed up chemical reactions
in the human body. They bind to molecules
and alter them in specific ways. They are
essential for respiration, digesting food,
muscle and nerve function, among
thousands of other roles.
BIOMEDICAL IMPORTANCE
 Without enzymes, life as we know it would
not be possible.
 enzymes occupy central roles in health &
diseases.
 Enzymes give information to physicians in
diagnostic & prognosis.
 Deficiency may leads to inborn errors of
metabolism.
CLASSIFICATION
 IUB system of enzyme classification.
 Enzymes are divided into 6 major
classes.
OTH LIL
1. OXIDOREDUCTASES
 ENZYMES INVOLVED IN OXIDATION- REDUCTION
REACTIONS.
oxidation reduction
AH2 + B A + BH2
Eg.; alcohol dehydrogenase,
lactate dehydrogenase, xanthin oxidase,
G-6-P dehydrogenase, cytochrom oxidase.
2.TRANSFERASES
 ENZYMES THAT CATALYSE THE TRANSFER
OF FUNCTIONAL GROUPS FROM ONE
SUBSTRATE TO ANOTHER.
A – X + B A+B – X
Eg; hexokinase,
transaminases, transmethylases,
phosphorylases.
3. HYDROLASES
 ENZYMES THAT BRING ABOUT
HYDROLYSIS OF VARIOUS
COMPOUNDS.
A-B + H2O AH + BOH
Eg; lipase,cholin esterase, acid & alkaline
phosphatases, pepsin, urease.
4. LYASES
 ENZYMES SPECIALYSED IN THE ADDITION
OR REMOVAL OF WATER, AMMONIA, CO2 etc.
addition elimination
A-B + X-Y AX – BY
Eg; aldolase, fumarase, histidase.
5.ISOMERASES
 ENZYMES INVOLVED IN ALL THE
ISOMERISATION REACTIONS.
Eg; triose phosphate isomerase
retinal isomerase, phosphohexose isomerase,
Epimerase.
6. LIGASES
 ( Greek: ligate – to bind)
 ENZYMES CATALYSING THE SYNTHETIC
REACTIONS WHERE TWO MOLECULES ARE JOINED
TOGETHER & ATP IS USED.
A + B A - B
ATP ADP+Pi
Eg; glutamine synthetase, acetyl CoA carboxilase,
succinate thiokinase, DNA ligase.
EC Number
 The Enzyme Commission Number (EC
Number) is a numerical classification
scheme for enzymes, based on the
chemical reactions they catalyze.
CHEMICAL NATURE &
PROPERTIES OF ENZYMES
 ALL THE ENZYMES ARE PROTEIN IN NATURE
WITH LARGE mol.Wt., EXCEPT RIBOZYMES.
 THE FUNCTIONAL UNIT OF AN ENZYME IS
KNOWN AS HOLOENZYMES, WHICH IS
OFTEN MADE UP OF APOENZYME (THE
PROTEIN PART) AND A COENZYME (THE
NON-PROTEIN PART).
holoenzyme apoenzyme+coenzyme
(active enzyme) (protein part) (non-proteinpart)
 THE TERM PROSTHETIC GROUP IS USED
WHEN THE NON-PROTEIN MOIETY TIGHTLY
BINDS WITH THE APOENZYME.
 MONOMERIC ENZYMES made up of a single
polypeptide.
Eg; ribonuclease, trypsin.
 Some of the enzymes which posses more than one
polypeptide chain are known as OLIGOMERIC
ENZYMES.
Eg; lactate dehydrogenase, aspertate
transcarbamoylase, etc.
 When many different enzyme catalyzing
reaction sites are located at different sites of
the same macromolecule, it is called
MULTIENZYME COMPLEX.
Eg; fatty acid synthetase, carbamoyl phosphate
synthetase II, pyruvate decarboxylas, etc.
FACTORS EFFECTING ENZYME
ACTIVITY
 Enzyme activity can be affected by a variety
of factors, such as temperature, pH, and
concentration. Enzymes work best within
specific temperature and pH ranges, and
sub-optimal conditions can cause an enzyme
to lose its ability to bind to a substrate.
FACTORS EFFECTING ENZYME
ACTIVITY
1. CONCENTRATION OF ENZYME
 As the concentration of the enzyme is
increased, the velocity of the reaction
proportionately increases.
2. SUBSTRATE CONCENTRATION
 Increase in substrate concentration
gradually increases the velocity of enzyme
reaction within the limited range substrate
levels.
 A rectangular hyperbola curve is obtained
when velocity is plotted against the
substrate concentration.
A. At low substrate concentration, the velocity
of the reaction is directly proportional to
the substrate level.
B. As the substrate is increased, the substrate
concentration is not directly proportional to
the enzyme activity. (1/2 Vmax ) .
C. Further increase in substrate can not make
any effect in reaction velocity, the reaction
is independent of the substrate
concentration. The maximum velocity is
obtained is called ( Vmax ) .
MICHAELIS-MENTEN CONSTANT
(Km )
IS DIFINED AS THE SUBSTRATE
CONCENTRATION TO PRODUCE ½ MAXIMUM
VELOCITY IN THE ENZYME CATALYSED
REACTION.
 Km is independent of enzyme concentration.
 Km is the signature of the enzyme ( Km valve
is thus a constant for an enzyme ).
 Km denotes the affinity of enzyme for
substrate.
Vmax
V=
Km + [S]
V= measured velocity
Vmax = maximum velocity
S= substrate concentration
Km= michaelis-mentan constant
WHAT IS Km VALUE ?
THE SUBSTRATE CONCENTRATION AT HALF
MAXIMAL VELOCITY
3. EFFECT OF TEMPERATURE
 VELOCITY OF AN ENZYME REACTION
INCREASES WITH INCREASE IN
TEMPARATURE UP TO A MAXIMUM AND
THEN DECLINES. A BELL SHAPED CURVE IS
USUALLY OBTAINED.
 . The optimum temperature for most of the
enzymes is between 40°C-45°C. However, a few
enzymes (e.g. venom phosphokinases, muscle
adenylate kinase) are active even at 100°C
 In general, when the enzymes are
exposed to a temperature above 50°C,
denaturation leading to derangement in
the native (tertiary) structure of the
protein and active site are seen. Majority
of the enzymes become inactive at
higher temperature (above 70°C).
4. EFFECT OF pH
 EACH ENZYME HAS AN OPTIMUM pH AT
WHICH THE VELOCITY IS MAXIMUM.
 EITHER INCREASE OR DECREASE IN pH
ENZYME ACTIVITY DRASTICALLY
DECREASED.
 Most of the enzymes of higher organisms
show optimum activity around neutral pH (6-
8). There are, however, many exceptions like
pepsin (1-2), acid phosphatase (4-5) and
alkaline phosphatase (10-11) for optimum pH.
5. EFFECT OF PRODUCT
CONCENTRATION
 THE ACCUMULATION OF REACTION
PRODUCTS GENERALLY DECREASES THE
ENZYME VELOCITY.
 IT IS ACHIVED THROUGH FEED BACK
MECHANISM.
 For certain’ enzymes, the products combine
with the active site of enzyme and form a
loose complex and, thus, inhibit the enzyme
activity. In the living system, this type of
inhibition is generally prevented by a quick
removal of products formed.
6. EFFECT OF ACTIVATORS
 SOME OF THE ENZYMES REQUIRE CERTAIN
INORGANIC METALLIC CATIONS LIKE Mg,
Mn, Zn, Ca, Co. Cu, etc., FOR THEIR OPTIMUM
ACTIVITY.
Metal activated enzymes
 Metal activated enzymes are enzymes that
have an increased activity due to the
presence of metal ions. ... However, these
ions are not tightly bound with the enzyme as
in metalloenzymes. The metal can activate
the substrate, thus engage directly with the
activity of the enzyme.
 Metalloenzymes are enzymes that contain
a tightly bound metal ion.
7. EFFECT OF TIME
UNDER IDEAL CONDITIONS (PH,
TEMPERATURE) THE TIME REQUIRED FOR
AN ENZYME REACTION IS LESS.
8.EFFECT OF LIGHT AND RADIATION
 EXPOSURE OF ENZYMES TO UV, & X- RAYS
INACTIVATES CERTAIN ENZYMES DUE TO
FORMATION OF PEROXIDES.
Eg; UV rays inhibit salivary amylase.
ACTIVE SITE
 DEFINITION: THE ACTIVE SITE OF AN ENZYME
IS DEFINED AS THE SMALL REGION OF THE
ENZYME WHERE SUBSTRATE BINDING AND
CATALYSIS OCCURS IS REFFERED TO AS
ACTIVE SITE.
SALIENT FEATURES:-
 The existence of active site is due to
the tertiary structure of protein
resulting in the three dimensional
native conformation. Loss of native
enzyme structure will result in
derangement of active site.
 Although all parts are required for keeping
the exact three dimensional structure of the
enzyme, the reaction taking place at active
site. The active site occupies only a small
portion of whole enzyme.
Eg; lysozyme has 129 amino acids . The active
site formed by 35,52,62,63& 101 amino acids.
 Active sites are regulated as CLEFTS OR
CERVICES occupying a small region in a big
enzyme molecule.
 Active site is FLEXIBLE not RIGID.
 It possesses SUBSTRATE BINDING SITE &
CATALYTIC SITE.
 The substrate binds at active site by non-
covalent bonds. There forces are
hydrophobic in nature.
 Enzyme specificity is due to active site.
 The amino acids ser, asp., his, lys, arg, tyr, are
repeatedly found at active site.
ENZYME INHIBITION
 An enzyme inhibitor is a molecule that
binds to an enzyme and decreases
its activity. By binding to enzymes' active
sites, inhibitors reduce the compatibility
of substrate and enzyme and this leads
to the inhibition of Enzyme-Substrate
complexes' formation, preventing the
catalysis of reactions and decreasing (at
times to zero) the amount of product
produced by a reaction.
 It can be said that as the concentration of
enzyme inhibitors increases, the rate of
enzyme activity decreases, and thus, the
amount of product produced is inversely
proportional to the concentration of
inhibitor molecules. Since blocking an
enzyme's activity can kill a pathogen or
correct a metabolic imbalance, many
drugs are enzyme inhibitors. They are
also used in pesticides.
 Not all molecules that bind to enzymes
are inhibitors; enzyme activators bind to
enzymes and increase their enzymatic
activity, while enzyme substrates bind
and are converted to products in the
normal catalytic cycle of the enzyme.
ENZYME INHIBITION
 Enzyme inhibitor is defined as a substance which
binds the enzyme and brings about a decrease in
catalytic activity.
 The inhibitor may be organic or inorganic in
nature.
 Enzyme inhibitor is a substance which binds with
the enzyme and brings about a decrease in the
catalytic activity of that enzyme
 Three broad categories of enzyme
inhibition.
1. Reversible inhibition
2. Irreversible inhibition
3. allosteric inhibition
1.REVERSIBLE INHIBITION
The inhibitor binds non-covalently with
enzyme and the enzyme inhibition can be
reversed if the inhibitor is removed. Is
further sub-divided into-
i. competitive inhibition
ii. Non- competitive inhibition
iii. Un- competitive inhibition
i. COMPETITIVE INHIBITION
Here the inhibitor (I) closely resembles
the normal substance (S) is regarded as
SUBSTRATE ANALOHGUE.
 As long as the inhibitor holds the active
site, the enzyme is not available for the
substrate to bind.
 During the reaction , ES & EI complexes are
formed.
E + S ES E+P
+
I
EI
 Here the reaction velocity is decreased.
 Excess substrate abolishes the inhibition.
 Km is increased, Vmax unchanged.
COMPETITIVE INHIBITION CONT..
CLINICALLY USEFUL COMPETITIVE
INHIBITORS
DRUG ENZYME
INHIBITED
CLINICAL USE
1.Allopurinol
2.Dicoumarol
3.Pencillin
4.methotrexat
e
Xanthine oxidase
Vit.K epoxide
reductase
Trans peptidase
FH2- reductase
Gout
Anti-coagulant
Bacteria
cancer
ii. NON-COMPETITIVE INHIBITION
 The inhibitor binds at site other than active
site.
 This binding impairs enzyme function.
 No structural resemblance with the
substrate.
 Km is unchanged, Vmax islowered.
 Increase in substrate concentration can’t
abolish non-competitive inhibition.
 3D structure may abolish.
 The inhibitor binds with enzyme as well as
the ES complex.
E + S ES E+P
+ +
I I
EI EIS
 Heavy metal ions (Ag,Pb,Hg,etc.,) can non-
competitively inhibit the enzyme.
iii. UN-COMPETITIVE INHIBITION
 The inhibitor doesn't binds with enzyme but only
binds with ES complex.
 Un-competitive inhibitor decreases both Km & Vmax .
E + S ES E+P
+
I
ESI
 Inhibition of placental ALP by phenylalanine
is an Eg. Of un-competitive inhibition.
2. IRREVERSIBLE INHIBITION
 The inhibitors binds covalently with the
enzymes and inactivate them.
 These inhibitors are usually toxic
substances.
Eg: IODOACETATE is an irreversible inhibitor of
papain & G3PDH.
Iodoacetate combines with –SH groups at
active site & inactivate the enzyme.
 CYANID inhibits Cytochrome oxidase.
 FLUORIDE removes MG & Mn ions & so
inhibit enolase of glycolysis.
 DI-ISOPROPYL FLUROPHOSPHATE(DFP) is a
nerve gas developed by Germans during 2nd
world war. It inhibits the enzymes containing
Ser at the active site. Eg; serine protease,
acetyl choline, esterase, ( which has imp.
function in nerve transmission).
SUICIDE INHIBITION
 IT IS SPECIAL TYPE OF IRREVERSIBLE
INHIBITION.
 In this, the structural analogue is converted
to a more effective inhibitor.
Eg; 1. ALLOPURINOL which is oxidized by
xanthine oxidase to ALLOXANTHIN that is a
strong inhibitor of xanthin oxidase.
2. Ornithine difluro methyl
decarboxilase ornithine (DFMO)
Is a inhibitor of trypanosomiasis (sleeping
sickness).
3. 5-flurouracil fluro deoxy uridylate
used in chemotherapy.
ENZYME SPECIFICITY
 Specificity is a characteristic nature of the
active site.
 Enzymes are high specific in their action.
 The occurrence of thousands of enzymes is
due to specific nature of enzymes.
 It is three types.
1. Stereospecificity
2. Reaction specificity
3. Substrate specificity.
1.Stereo or optical specificity
 Stereoisomers are the compounds which
have the same molecular formula , but differ
in their structural configuration.
 Human enzymes are specific for L-A.A’s &
D-carbohydrates.
 The enzymes act on one isomer.
Eg; L-A.A oxidase & D-A.A oxidase acts on
L&D-A.A’s.
 Hexokinase acts on D-hexoses
 Glucokinase acts on D-glucose.
 Amylase acts on α-glycosidic linkages.
2.REACTION SPECIFICITY
 The same substrate can undergo different
types of reactions, each catalysed by specific
enzyme.
 Amino acids can undergo transamination,
deamination, decarboxilation, etc,.
A.A oxidase keto acid
A.A decarboxilase amine
3. SUBSTRATE SPECIFICITY
 It is divided into 3 types
a. Absolute specificity
b. relative specificity
c. broad specificity.
a. Absolute substrate specificity
 Certain enzymes act only on one substrate.
Eg; glucokinase
glucose glucose-6-phosphate
urease
urea ammonia + co2
b. Relative substrate specificity
 Enzymes act on structurally related
substances.
 Its may depends on BOND or GROUP.
Eg; trypsin hydrolyses peptide linkages
involved in trp., lys.
 CHYMOTRYPSIN cleaves phe, tyr, trp.
 GLYCOSIDASES cleaves glycosidic bonds.
c. Broad specificity
 This enzymes act on closely related
substances
Eg; hexokinase acts on glucose. Fructose,
mannose.
COENZYMES
 DEFINITION : the non-protein, organic, low
mol.wt and dialysable substance associated
with enzyme function is known as coenzyme.
 Only protein part of enzyme can’t participate
in catalytic activity.
 Many enzymes require coenzymes for
catalysis.
 The cofactors may organic or inorganic in
nature.
 The functional enzyme is referred to as
HOLOENZYME which is made up of a protein
part APOENZYME and non-protein part
COENZYME.
 Coenzymes undergo alterations during
enzyme reactions, which are later
regenerated. This is in contrast to the
substrate which is converted to the product.
 Coenzymes participate in various reactions
involving transfer of atoms or groups like
hydrogen, aldehyd, keto, amino, acyl, methyl,
etc.
 Coenzymes play a imp. role in enzyme
function.
 The specificity of enzyme is mostly
dependent on the apoenzyme and not on the
coenzyme.
 It is heat stable.
CO-ENZYMES FROM B-COMPLEX VITAMINS:
 Most of coenzymes are the derivatives of
B-complex vitamins.
Eg; TPP, FMN, FAD, NAD+, NADP+, PLP, CoA,
NON-VITAMIN CO-ENZYMES :
 Not all coenzymes are vitamin derivatives.
There are some other organic substances,
which no relation with vitamins.
Eg; ATP, CDP, UDP, SAM, PAPS.
NUCEOTIDE CO-ENZYMES :
 Some enzymes possess nitrogenous base,
sugar and phosphate. Such coenzymes are
known as nucleotide coenzymes.
eg; NAD+, NADP+, FMN, FAD, CoA.
MECHANISM OF ENZYME ACTION
 Catalysis is prime function of enzyme.
 For any chemical reaction to occur, the
reactants have to be in an activated or
transition state.
 There are few theories explaining the
MEHANISM OF ACTION OF ENZYMES.
Enzyme lower activation energy
 Enzymes lower the energy of activation.
 Activation energy is defined as the energy
required to convert all molecules of a
reacting substance from the ground state to
the transition state.
 The reactants when heated attain the
activation energy.
 Enzymes don't alter the equilibrium
constant, they only enhance the velocity of
the reaction.
 The enzyme reduces the activation energy.
Eg; activation energy needed for
decomposition of H2O2 is 765KJ/mol. In the
presence of platinum, it is 49KJ/mol.and in
the presence of enzyme, the activation
energy is <8KJ/mol.
ENZYME SUBSTRATE COMPLEX
FORMATION
 The prime requisite for enzyme is that the
substrate (S) must combine with the enzyme
(E) at the active site to form enzyme-
substrate complex (ES) which ultimately
results in the production formation (P).
E+S ES E+P
LOCK & KEY MODEL or FISCHER’S
TEMPLATE THEORY
 It is the first model proposed to explain an
enzyme catalysed reaction.
 ACCORDING TO THIS MODEL,
1. Structural confirmation of enzyme is rigid
2. Active site is complementary to the
substrate.
 Which could not explain the flexibility
shown by enzymes.
INDUCED FIT THEORY or
KOSHLAND’S MODEL
 It is more acceptable and realistic model for
ES complex formation.
 AS PER THIS MODEL,
– The active site is not rigid & pre-shaped.
– Substrate binds to a specific part of the enzyme.
– The substrate induces conformational changes
in the enzyme.
 Allosteric inhibition can also be explained by
the hypothesis of koshland.
 It has experimental evidence from the X-ray
diffraction studies.
SUBSTRATE STRAIN THEORY
 In this model, the substrate is strained due to the
induced confirmation change in the enzyme.
 When substrate binds to the preformed active site,
the enzyme induces a strain to the substrate.
 The strained substrate leads to the product
formation.
 It explains the role of enzyme in increasing the rate
of reaction.
REGULATION OF ENZYME ACTIVITY
– The Enzyme activity can be regulated by two
means
 Altering the activity of existing enzyme
(fine control)
 Altering the concentration of enzymes
(coarse control)
REGULATION OF ENZYME ACTIVITY- I
–Allosteric regulation
–Feed back inhibition
–Regulation by covalent modifications
–Activation of latent enzymes
REGULATION OF ENZYME ACTIVITY- II
 Induction and repression of enzyme
synthesis others
 Compartmentation of metabolic pathways.
 Substrate concentration
ALLOSTERIC REGULATION
 Enzymes possess additional sites, known as
allosteric sites such enzymes are known as
allosteric enzymes
 Allosteric modulators bind at the allosteric site
regulate the enzyme activity.
 Enzyme activity increased when a +ve allosteric
effector binds at the allosteric site
 Enzyme activity maybe decreased when a –ve
allosteric effector binds at the allosteric site
CLASSES OF ALLOSTERIC
ENZYMES
Depending on Vmax
and Km
K-Class of Enzymes V-Class of Enzymes
Changes Km and not Vmax Changes Vmax and not Km
Similar to competitive group
Non-competitive group
PFK involvedin glycolytic pathway
Acetyl-COA carboxylase involvedin
fatty acid synthesis
MECHANISM OF ALLOSTERIC
REGULATION
 Most of allosteric enzymes are oligomers
 Subunits may be identical or different
 Effector binds non-covalently to a site other than the active
site and this regulatory site may be located on a subunit that
it self may not be catalytic subunit
 A conformational change occurs in the active site of the
enzyme leading either to activate or inhibition of the enzyme
depending on the type of effector
 Accordingly allosteric enzymes in the conformational states
that T (Tense or Taut) and the R (Relaxed)
- T form low affinity form for substrate
- R form high affinity form for substrate
 So inhibitor favors T form and activator favors R form
TYPE OF EFFECTOR
HOMOTROPIC EFFECTOR
 When the substrate itself serves as an effector
it is called as homotropic effector
 That is the substrate influences the substrate
binding though allosteric mechanism.
 Their effective is always positive.
 These enzymes show a sigmoidal curve when
velocity is plotted against substrate
concentration. This contrasts with the
hyperbolic curve charcteristic of enzymes
which follow Michaelis-Menten equation
HETEROTROPHIC EFFECTER
• When the effecter is different from the
substrate that is called Heterotrophic
effecter
 Heterotrophic interactions are either +ve
or -ve.
ENZYMES WITH ALLOSTERIC
EFFECTORS
 Features of allosteric inhibition
– Inhibition not a substrate analogue
– Partially reversible when excess substrate
added
– Km is usually increased
– Vmax is usually decreased
– Most allosteric enzymes possess quaternary
structure .
ENZYMES WITH ALLOSTERIC
EFFECTORS
Enzyme Metabolic pathway Inhibitor Allosteric
Activator
Hexokinase Glycolysis
Glucose6-
Po4
-
Phosphfruct
okinase
Glycolysis ATP AMP,ADP
Pyruvate
carboxylase
Glucooneogeonesis _ Acetyl CoA
Acetyl CoA
carboxylase
Fatty acid synthesis Palmitate Isocitrate
FEED BACK INHIBITION
 process of inhibiting the first step by the
final product in a series of enzyme
catalyzed reaction of a metabolic
pathway is referred to as feed back
inhibition
 A e1 B e2 C e3 D e4 E
 Initial substrate Final substrate
FEED BACK INHIBITION OF METABOLIC PATHWAY
 When the final product E inhibits the first step it is
called as feed back regulation/ negative feed back
regulation because the product E ultimately stops
its own synthesis
 This is an effective mechanism because, it saves
the energy expenditure involved in the synthesis of
a compound which is already available with in the
cell
E.g.
1. Aspartate trans carbamoylase (ATCase)
(pyrimidine metbolism)-CTP inhibits ATCase
2. HMG-COA reductase(Cholesterol biosynthesis)
REGULATION BY COVALENT
MODIFICATION
 Many enzymes exists in the active and inactive form
which are intercovertible depending upon the
needs of the body
 Covalent modification is the change in the activity of
the enzyme by either adding a group to enzyme
protein by covalent bond or removing a group by
cleaving a covalent bond.
 Includes,
1. Phosphorylation and dephosphorylation
2. Adenylation and deAdeylation
3. ADP ribosylation,Uridylation ,Methylation
• Control of phosphorylation and
dephosphorylation is mainly exhibited by the
hormones like (epinephrine, thyroxine etc)
and an enzyme may be active in the
phosphorylated state or dephosphorelated
state
 E.g. Glycogen phosphorylase an enzyme involved in
cleavage of glycogen to provide glucose or energy
 Phosphorylase exists in the forms
A B
dePhosphorylated form phosphorylated form
inactive form active form
 Like wise some enzymes are active in the
deposphorylated state and become inactive
when phosphorylated
 E.g. Glycogen synthase, Acetyl coa
carboxylase
ACTIVATION OF LATENT ENZYMES
 Some enzymes exists in latent forms and
latent forms as such are inactive for Eg
enzymes may be synthesized as proenzymes
or zymogens which undergo irreversible
covalent activation by the breakdown of one
or more peptide bonds
 E.g. chymotripsinogen, trypsinogen, and
plasminogen are respectively converted to
chymotrypsin, trypsin and plasmin
COARSE CONTROL
 Modification in the concentration of the
enzyme this is done by regulating the rate of
enzyme synthesis that is Induction and
repression of enzyme synthesis
 Induction – Increased synthesis of the
enzyme
 Repression – Decreased synthesis of the
enzyme
 This is coordinated at the level of gene and is
also mediated mainly through the hormones
COARSE CONTROL
 E.g. Hormone insulin induces the enzyme
involved in the utilization of glucose
 1. Glucokinase
 2. Phospho fructokinase
 3. Pyruvate kinase
 Like wise insulin represses enzyme involved in
glucose synthesis (gluconeogenesis) like
Glucose-6phosphatase
 ,fructose-1,6biphosphatase
COMPARTMENTATION OF
METABOLIC PATHWAYS
 Certain substances in the body are both
synthesized and also degraded in the body and
there is no point for simultaneous occurrence
of both
 So this can be regulated by compartmentation
that is synthesis pathway occurs in one
organelle and breakdown pathway occurs in
other organelle
 E.g. fatty acid synthesis take place in
cytoplasm, fatty acid degradation take place in
mitochondria, more over enzymes of the same
pathway may be present in cytoplasm and
mitochondria
 Some may be present
only in cytoplasm and
some only in
mitochondria
 Eg Heme synthesis
Urea cycle
Gluconeogenesis
For all the these pathways some
Enzyme may be located In
cytoplasm some may be in
mitochondria and so the
intermediates have to be
Shuttled across the
mitochondrial
membrane. This provides a point
where again control can be
exerted
MECHANISMS FOR REGULATING
ENZYME ACTIVITY
CLINICAL
ENZYMOLOGY
CLINICAL APPLICATION OF
ENZYMES
 Enzymes are present in all the tissues
 It is having different applications clinically
1. Diagnosing a disease
2. To diagnose a congenital disorder
3. Measurement of compounds
4. As therapeutic agents
5. Enzymes linked to insoluble materials are used
as chemical reactors.
6. Most of the drugs are acting by inhibiting the
enzymes
IN DIAGNOSIS OF DISEASE
Enzyme Tissue affected
Amylase Pancreas
Lipase Pancreas
AST Cardiac , hepatic
ALT Hepatic inflammation
ALP Hepatic obstruction, bone
GGT Hepatic damage
Creatinine kinase Brain, cardiac / skeletal
Ck- MB Necrosed cardiac tissue
Acid phosphatase Prostate
LDH Cellular lysis,non- specific
ENZYMES IN DIAGNOSIS
Functional Non- functional
Specific to plasma
Have definite function
Present in high
concentration
Enters plasma from tissues
No function in plasma
Normally the level will be
low
These non- functional enzymes are more
important for clinician to diagnose a disease
ENTRY OF TISSUE ENZYMES
INTO PLASMA
They enter
 when disease process cause changes in
cell membrane permeability
 When cell dies
 Since there is gross difference between
intracellular and extra cellular
concentration
PATTERN OF ENTRY OF ENZYMES
 Greater the tissue damage larger will be the
concentration of enzymes in plasma
 Cytosolic enzymes will appear before
mitochondrial enzymes
ENZYME LEVELS IN PLASMA
 The levels are maintained by the following
factors
1. Rate of release of enzymes into plasma
2. Stability of enzymes in plasma
3. The clearance rate of enzymes by reticulo -
endothelial system (Half –life)
WHAT AN ENZYME DOES
E+S ES EP E+P
 The enzyme (E) binds substrate (S) and
converts it to product (P).
 Note that E recycles.
 Overall, S P
MEASUREMENT OF ENZYME
CK
CrP + ATP creatine + ADP
pH 9.0
PK
ADP+ phosphoenol pyruvate ATP+ pyruvate
LD
Pyruvate + NADH +H Lactate+ NAD
The change in absorbance produced in
this reaction is a measure of enzyme
activity
WE CALL THIS MEASUREMENT AN
ENZYME ASSAY.
 Decrease in substrate or
 Increase in product
 Typically change in absorbance
0 30 s 1 min 2 min 4 min 8 min
INCREASE SUBSTRATE
CONCENTRATION
2
1 3 4 5 6 7 8
0
Product
80
60
40
20
0
S
+
E
↓
P
(
in
a
fixed
period
of
time
)
0 2 4 6 8
Substrate (mmole)
HOW WE MEASURE ENZYME
ACTIVITY
 Choose best conditions. All these variables affect
reaction.
– Temperature
– pH
– enzyme concentration
– substrate concentration
– co-factors
– Inhibitors
 Keep everything constant except one variable, and
study that.
ENZYME ACTIVITY OFTEN MEASURED AS
COLOUR CHANGE
Time
Absorbance
S P
Increase in absorbance
over time is not linear.
This is because of back-
reaction (or sometimes
the product inhibits).
ENZYME ACTIVITY OFTEN MEASURED AS
COLOUR CHANGE
Time
Always measure INITIAL rate
Express this as DA/time (vo).
A
b
s
o
r
b
a
n
c
e
© 2007 Chettinad Hospital & Research Institute
-4 -2 0 2 4
1/[S]
0 1 2
[S]
no
1
2
3
4
0.25
0.50
1.0
2.0
0.42
0.72
0.80
0.92
Absorbance v (mmole/min)
[S]
0.21
0.36
0.40
0.46
(1) The product was measured by spectroscopy at 600 nm for 0.05 per mmole
(2) Reaction time was 10 min
1/S 1/v
4
2
1
0.5
2.08
1.56
1.35
1.16
→
→
→
→
v
Direct
plot
Double
reciprocal
2.0
1.0
0
1/v 1.0
-3.8
no
1
2
3
4
0.25
0.50
1.0
2.0
0.42
0.72
0.80
0.92
Absorbance v (mmole/min)
[S]
0.21
0.36
0.40
0.46
1/S 1/v
4
2
1
0.5
2.08
1.56
1.35
1.16
→
→
→
→
1.0
0.5
0
v
2.0
1.0
0
1/v 1.0
-3.8
Data
Velocity
Substrate Product Double reciprocal
A REAL EXAMPLE FOR ENZYME KINETICS
ENZYMES PATTERNS (ENZYME PROFILES) IN DISEASES
© 2007 Chettinad Hospital & Research Institute
Hepatic Disease
1. Alanine Amino
Transferase (ALT)
Marked Increase in
parenchymal liver disease
2. Nucleotide
phosphatse (NTP)
Elevated in liver dysfuntion
with cholestasis
3. Alkaline
phosphatse (ALP)
Marked increase in
obstructive Liver disease
4. Gamma Glutamyl
transferase
Increase in obstructive and
alcoholic liver disease
Myocardial Infarction
1. Creatine Kinase
First enzyme to rise followin infarction,
CK-MB iso-enzyme is specific
2. Aspartate Amino
Transferase
rise after the rise of CK and return to
normal in 4 - 5 days
3. Lactate Dehydrogenase
Last enxyme to rise. LDH-1 becomes
more than 2 (Flipped Pattern)
(ENZYME PROFILES) IN DISEASES CONT
Bone Disease
Alkaline Phosphates
Marked Elevation in Osteoblastic bone
activity as in rickets.
Labile bone isoenzyme is elevated. Also
in paget’s Disease
(Enzyme profiles) in diseases cont
Muscle Disease
1. Creatine Kinase (CK - MM)
Marked increase in Muscle Disease.
CK - MM fraction is elevated.
2. Aspartate amino Transferase
(AST)
Shows an increase in different
types of muscle disease; not
specific
3. Aldolase (ALD)
Earliest enzyme to rise, but not
specific
Prostate Cancer
1. Prostatic Specific
Antigen
Marker for Prostate Cancer. Mild increase in
benign prostate enlargement
2. Acid Phosphatase
Marker for Prostate Cancer. Metastatic bone
disease especially from a
Primary from prostate. Inhibited by L
tartrate.
CLINICAL SIGNIFICANCE OF ISO-ENZYMES
Separation of Iso-Enzymes by
1. Heat stability
2. Gel Electrophoresis
3. Immuno Elctrophoresis
4. Lectin Binding Assay
5. Monoclonal Antibodies
CREATININE KINASE – TOTAL
•Death of cardiac tissue
•Skeletal Muscle Injury
•Brain Disorders
•To Distinguish CK – MB, CK-MM and CK – BB
can be done.
•If any one increase Total Will increase
CREATININE KINASE ISOENZYMES PATTERNS
Tissue CK1 BB CK2 MB CK3 MM
Brain
97.3 2.7 0
Heart
1.3 20 78.7
Skeletal
Muscle
0.06 1.1 98.9
INCREASE IN CK - TOTAL
• Myocardial Infarction
• Severe muscle disorder
• Myopathies
• Fertiliser Poisoning (Organo Phosphorus
Compounds)
• Brain injuries, surgeries.
ALKALINE PHOSPHATASE (ALP)
• Liver – 50 %
• Bone – 50 %
• Kidney
• Small Intestine
• Placenta
Algorhythm
Sole Elevation of
ALP
Age of the patient
(Childhood & Adolescence)
High due to bony growth
No need to proceed
No need to proceed
Pregnant
No need to
proceed
Do Liver Enzyme
Gamma GT /
5 Nucleotidase
Normal
Do the Heat
Stability
Test
High
No need to
proceed
HOW TO INTERPET? if there is abnormal ALP.
•In moderate increase see the age and sex
of patient. If the patient is in growth spurt
then it is physiological increase due to
bony growth (Osteoblastic Action)
•If the patient is Female and pregnant then
the increase may be due to release from
placenta
•If it is due to Liver other enzymes
pertaining to it can be measured if
normal ------ rule out liver disorder
•Do the heat stability test --- Liver
fraction denatures but bony fraction is
stable to heat. So if the levels are still
high after heating it at 57c then the
enzymes may be of bony origin (It will
increase in bony cancer (or) fracture but
the increase occurs in osteoblastic
conditions
•If Measurement is done after heavy fat
meal then mild increase in ALP may be
noticed due to origin from small
intestine.
ESTIMATION OF CERTAIN COMPOUNDS (EG.,
GLUCOSE, CHOLESTEROL)
•Earlier 2 decades ago Glucose is estimated
based on their chemical property ,reducing
activity of sugars. But there are other reducing
agents which may come and interfere.
• Hence now a days Glucose is measured by
Glucose Oxidase enzyme. Here the enzyme is so
specific and we may get true value of Glucose in
Plasma.
Enzyme Used for testing
Urease
Uricase
Glucose Oxidase
Peroxidase
Hexokinase
Cholesterol Oxidase
Lipase
Horse Radish Peroxidase
Alkaline Phosphatase
Restriction Endonuclease
Reverse Transcriptase
Urea
Uric Acid
Glucose
Glucose; Cholesterol
Glucose
Cholesterol
Triglycerides
ELISA
ELISA
Southern blot; RFLP
Polymerase Chain Reaction
ENZYMES USED FOR DIAGNOSTIC PURPOSE
PRINCIPLE OF CHOLESTEROL ESTIMATION
Cholesterol Oxidase
Cholesterol + O2 H2O2 +
Cholest - 4 en- 3 one
Peroxidase
H2O2 H2O +O
O + Colorless Dye colored Dye
which is measured at particular wavelength and it is
directly proportional to cholesterol level in blood
Simple Machines which can give you the results with in few
minutes.
ELIZA
• In the modern Clinical Chemistry  ELIZA Plays an
important role.
• Especially when we have to measure which are present
in nano grams
E.g. Hormonal Assay and Assay of Proteins present in very
low concentration
• It is Based on the Principle that Antigen is captured by the
specific monoclonal
• Antibody which are tagged by enzymes and its
subsequent reaction with substrate in negligible amounts.
• (Beneficial effect from the wedding of enzyme chemistry
am Immunology)
Enzyme Immuno Assay to
Detect or Measure Antibody
In a Patients Serum
Enzyme Immuno Assay
to detect an antigen .
E.g. Hepatitis B
Surface Ag
HBsAg
TO CONFIRM THE DIAGNOSIS OF THE CONGENITAL
METABOLIC DISORDERS
They are often due to deficiency of enzymes of one
(or) other metabolic pathway
1.Glucose 6 Phosphatase Von-Gierke’s disease
2.Glucose 6 phosphate dehydrogenase (G6PD) 
Hemolytic Anemia
Identification of deficient enzyme confirms the
diagnosis and gene therapy may help to over come
the hurdles in future.
ENZYMES AS THERAPEUTIC AGENTS
•Strepto kinase prepared from
streptococcus
•Tissue Plasminogen activator (t PA)
bioengineered in E- Coli Helps in
dissolving the blood clots leading to
myocardial infarction.
They convert the pro-enzyme
plasminogen to plasmin, which cleaves
the insoluble fibrin in to soluble
components.
ENZYMES AS THERAPEUTIC AGENTS - CONT
• The Concentration of Enzyme needed for
therapeutic achievement should be high
Since it is rapidly cleaved by Reticulo
Endothelial System.
• This difficulty will be overcome in
future, because the work is now going on
to couple enzyme to solid matrices and
they are implanted in highly perfused
area
Enzyme Therapeutic Application
Asparginase
Streptokinase
Urokinase
Streptodornase
Hyaluronidase
Pancreatin(Trypsin and Lipase)
Papain
Alpha 1 – Antitrypsin
Acute Lymphoblastic Leukemia
To lyse Intravascular Clot
Do
DNAse; applied locally
Enhances Local Anaesthetics
Pancreatic Insufficiency; oral
administration
Anti-Inflammatory
AAT Deficieny; Emphysema
EXAMPLES OF THERAPEUTIC USE OF ENZYMES
Thank you!

More Related Content

Similar to C.ENZYMOLOGY.ppt (20)

Enzymes
EnzymesEnzymes
Enzymes
 
Enzymes
EnzymesEnzymes
Enzymes
 
Enzymes and digestion2
Enzymes and digestion2Enzymes and digestion2
Enzymes and digestion2
 
Lec. 1 - Final.pptx
Lec. 1 - Final.pptxLec. 1 - Final.pptx
Lec. 1 - Final.pptx
 
Introduction -1st lec
Introduction -1st lecIntroduction -1st lec
Introduction -1st lec
 
Enzymes complete
Enzymes completeEnzymes complete
Enzymes complete
 
Enzymes and digestion
Enzymes and digestionEnzymes and digestion
Enzymes and digestion
 
Enzymes. classification. isoenzymes
Enzymes. classification. isoenzymesEnzymes. classification. isoenzymes
Enzymes. classification. isoenzymes
 
Enzymes.pptx
 Enzymes.pptx Enzymes.pptx
Enzymes.pptx
 
Enzymes
EnzymesEnzymes
Enzymes
 
Enzymes
EnzymesEnzymes
Enzymes
 
Catalysis lecture 4
Catalysis lecture 4Catalysis lecture 4
Catalysis lecture 4
 
Enzymes
EnzymesEnzymes
Enzymes
 
Enzymes. classification. isoenzymes
Enzymes. classification. isoenzymesEnzymes. classification. isoenzymes
Enzymes. classification. isoenzymes
 
Charcterstics of enzymes
Charcterstics of enzymesCharcterstics of enzymes
Charcterstics of enzymes
 
Enzymes.pptx
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
 
Enzymes
Enzymes Enzymes
Enzymes
 
Overview of enzyme
Overview of enzymeOverview of enzyme
Overview of enzyme
 
Enzymes
Enzymes Enzymes
Enzymes
 
ENZYMES - WEEK 1.ppt
ENZYMES - WEEK 1.pptENZYMES - WEEK 1.ppt
ENZYMES - WEEK 1.ppt
 

Recently uploaded

A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 

Recently uploaded (20)

A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 

C.ENZYMOLOGY.ppt

  • 2.  Enzymes are proteins that help speed up chemical reactions in our bodies. Enzymes are essential for digestion, liver function and much more. Too much or too little of a certain enzyme can cause health problems. Enzymes in our blood can also help healthcare providers check for injuries and diseases.
  • 3.  What are enzymes?  Enzymes are proteins that help speed up metabolism, or the chemical reactions in our bodies. They build some substances and break others down. All living things have enzymes.  Our bodies naturally produce enzymes. But enzymes are also manufactured .
  • 4.  What do enzymes do?  One of the most important roles of enzymes is to aid in digestion. Digestion is the process of turning the food we eat into energy. For example, there are enzymes in our saliva, pancreas, intestines and stomach.
  • 5.  They break down fats, proteins and carbohydrates. Enzymes use these nutrients for growth and cell repair.  Enzymes also help with:  Breathing.  Building muscle.  Nerve function.  Ridding our bodies of toxins.
  • 6.  What are the different types of enzymes?  There are thousands of individual enzymes in the body. Each type of enzyme only has one job. For example, the enzyme sucrase breaks down a sugar called sucrose. Lactase breaks down lactose, a kind of sugar found in milk products.
  • 7.  Some of the most common digestive enzymes are:  Carbohydrase breaks down carbohydrates into sugars.  Lipase breaks down fats into fatty acids.  Protease breaks down protein into amino acids.
  • 8.  What are the parts of an enzyme?  Each enzyme has an “active site.” This area has a unique shape. The substance an enzyme works on is a substrate. The substrate also has a unique shape. The enzyme and the substrate must fit together to work.
  • 9.
  • 10.  How do temperature and pH affect enzymes?  Enzymes need the right conditions to work. If conditions aren’t right, enzymes can change shape. Then, they no longer fit with substrates, so they don’t work correctly.
  • 11.  Each enzyme has an ideal temperature and pH:  pH: Enzymes are sensitive to acidity and alkalinity. They don’t work properly if an environment is too acidic or basic. For example, an enzyme in the stomach called pepsin breaks down proteins. If your stomach doesn’t have enough acid, pepsin can’t function optimally.
  • 12.  Temperature: Enzymes work best when your body temperature is normal, about (37°C). As temperature increases, enzyme reactions increase. But if the temperature gets too high, the enzyme stops working. That’s why a high fever can disrupt bodily functions.
  • 13.  How are enzyme tests used to diagnose health conditions?  Your healthcare provider can use a variety of enzyme and protein blood tests to check for certain health conditions. For example, elevated liver enzymes could be a sign of liver disease.
  • 14. ENZYMES DEFINITION: they are the catalysts of biological system, colloidal, thermolabile & protein in nature.
  • 15. erm Meaning Catalyst A substance that speeds up a chemical reaction without being changed Enzyme A biological catalyst (usually a protein) Substrate The reactant molecule that an enzyme works on Active site The part of the enzyme where the substrate binds
  • 16.  Enzymes: How they work and what they do
  • 17.  The part of the enzyme where the substrate binds is called the active site. Here, the enzyme changes shape slightly, fitting tightly with the substrate and forming the enzyme/substrate complex.
  • 18.
  • 19.  Enzymes help speed up chemical reactions in the human body. They bind to molecules and alter them in specific ways. They are essential for respiration, digesting food, muscle and nerve function, among thousands of other roles.
  • 20. BIOMEDICAL IMPORTANCE  Without enzymes, life as we know it would not be possible.  enzymes occupy central roles in health & diseases.  Enzymes give information to physicians in diagnostic & prognosis.  Deficiency may leads to inborn errors of metabolism.
  • 21. CLASSIFICATION  IUB system of enzyme classification.  Enzymes are divided into 6 major classes.
  • 23. 1. OXIDOREDUCTASES  ENZYMES INVOLVED IN OXIDATION- REDUCTION REACTIONS. oxidation reduction AH2 + B A + BH2 Eg.; alcohol dehydrogenase, lactate dehydrogenase, xanthin oxidase, G-6-P dehydrogenase, cytochrom oxidase.
  • 24. 2.TRANSFERASES  ENZYMES THAT CATALYSE THE TRANSFER OF FUNCTIONAL GROUPS FROM ONE SUBSTRATE TO ANOTHER. A – X + B A+B – X Eg; hexokinase, transaminases, transmethylases, phosphorylases.
  • 25. 3. HYDROLASES  ENZYMES THAT BRING ABOUT HYDROLYSIS OF VARIOUS COMPOUNDS. A-B + H2O AH + BOH Eg; lipase,cholin esterase, acid & alkaline phosphatases, pepsin, urease.
  • 26. 4. LYASES  ENZYMES SPECIALYSED IN THE ADDITION OR REMOVAL OF WATER, AMMONIA, CO2 etc. addition elimination A-B + X-Y AX – BY Eg; aldolase, fumarase, histidase.
  • 27. 5.ISOMERASES  ENZYMES INVOLVED IN ALL THE ISOMERISATION REACTIONS. Eg; triose phosphate isomerase retinal isomerase, phosphohexose isomerase, Epimerase.
  • 28. 6. LIGASES  ( Greek: ligate – to bind)  ENZYMES CATALYSING THE SYNTHETIC REACTIONS WHERE TWO MOLECULES ARE JOINED TOGETHER & ATP IS USED. A + B A - B ATP ADP+Pi Eg; glutamine synthetase, acetyl CoA carboxilase, succinate thiokinase, DNA ligase.
  • 29. EC Number  The Enzyme Commission Number (EC Number) is a numerical classification scheme for enzymes, based on the chemical reactions they catalyze.
  • 30.
  • 31.
  • 32. CHEMICAL NATURE & PROPERTIES OF ENZYMES  ALL THE ENZYMES ARE PROTEIN IN NATURE WITH LARGE mol.Wt., EXCEPT RIBOZYMES.
  • 33.  THE FUNCTIONAL UNIT OF AN ENZYME IS KNOWN AS HOLOENZYMES, WHICH IS OFTEN MADE UP OF APOENZYME (THE PROTEIN PART) AND A COENZYME (THE NON-PROTEIN PART).
  • 34.
  • 35. holoenzyme apoenzyme+coenzyme (active enzyme) (protein part) (non-proteinpart)  THE TERM PROSTHETIC GROUP IS USED WHEN THE NON-PROTEIN MOIETY TIGHTLY BINDS WITH THE APOENZYME.  MONOMERIC ENZYMES made up of a single polypeptide. Eg; ribonuclease, trypsin.
  • 36.  Some of the enzymes which posses more than one polypeptide chain are known as OLIGOMERIC ENZYMES. Eg; lactate dehydrogenase, aspertate transcarbamoylase, etc.
  • 37.  When many different enzyme catalyzing reaction sites are located at different sites of the same macromolecule, it is called MULTIENZYME COMPLEX. Eg; fatty acid synthetase, carbamoyl phosphate synthetase II, pyruvate decarboxylas, etc.
  • 38. FACTORS EFFECTING ENZYME ACTIVITY  Enzyme activity can be affected by a variety of factors, such as temperature, pH, and concentration. Enzymes work best within specific temperature and pH ranges, and sub-optimal conditions can cause an enzyme to lose its ability to bind to a substrate.
  • 39. FACTORS EFFECTING ENZYME ACTIVITY 1. CONCENTRATION OF ENZYME  As the concentration of the enzyme is increased, the velocity of the reaction proportionately increases.
  • 40.
  • 41. 2. SUBSTRATE CONCENTRATION  Increase in substrate concentration gradually increases the velocity of enzyme reaction within the limited range substrate levels.  A rectangular hyperbola curve is obtained when velocity is plotted against the substrate concentration.
  • 42. A. At low substrate concentration, the velocity of the reaction is directly proportional to the substrate level. B. As the substrate is increased, the substrate concentration is not directly proportional to the enzyme activity. (1/2 Vmax ) . C. Further increase in substrate can not make any effect in reaction velocity, the reaction is independent of the substrate concentration. The maximum velocity is obtained is called ( Vmax ) .
  • 43.
  • 44. MICHAELIS-MENTEN CONSTANT (Km ) IS DIFINED AS THE SUBSTRATE CONCENTRATION TO PRODUCE ½ MAXIMUM VELOCITY IN THE ENZYME CATALYSED REACTION.  Km is independent of enzyme concentration.  Km is the signature of the enzyme ( Km valve is thus a constant for an enzyme ).  Km denotes the affinity of enzyme for substrate.
  • 45. Vmax V= Km + [S] V= measured velocity Vmax = maximum velocity S= substrate concentration Km= michaelis-mentan constant
  • 46. WHAT IS Km VALUE ? THE SUBSTRATE CONCENTRATION AT HALF MAXIMAL VELOCITY
  • 47. 3. EFFECT OF TEMPERATURE  VELOCITY OF AN ENZYME REACTION INCREASES WITH INCREASE IN TEMPARATURE UP TO A MAXIMUM AND THEN DECLINES. A BELL SHAPED CURVE IS USUALLY OBTAINED.
  • 48.
  • 49.  . The optimum temperature for most of the enzymes is between 40°C-45°C. However, a few enzymes (e.g. venom phosphokinases, muscle adenylate kinase) are active even at 100°C
  • 50.  In general, when the enzymes are exposed to a temperature above 50°C, denaturation leading to derangement in the native (tertiary) structure of the protein and active site are seen. Majority of the enzymes become inactive at higher temperature (above 70°C).
  • 51. 4. EFFECT OF pH  EACH ENZYME HAS AN OPTIMUM pH AT WHICH THE VELOCITY IS MAXIMUM.  EITHER INCREASE OR DECREASE IN pH ENZYME ACTIVITY DRASTICALLY DECREASED.
  • 52.
  • 53.  Most of the enzymes of higher organisms show optimum activity around neutral pH (6- 8). There are, however, many exceptions like pepsin (1-2), acid phosphatase (4-5) and alkaline phosphatase (10-11) for optimum pH.
  • 54. 5. EFFECT OF PRODUCT CONCENTRATION  THE ACCUMULATION OF REACTION PRODUCTS GENERALLY DECREASES THE ENZYME VELOCITY.  IT IS ACHIVED THROUGH FEED BACK MECHANISM.
  • 55.  For certain’ enzymes, the products combine with the active site of enzyme and form a loose complex and, thus, inhibit the enzyme activity. In the living system, this type of inhibition is generally prevented by a quick removal of products formed.
  • 56. 6. EFFECT OF ACTIVATORS  SOME OF THE ENZYMES REQUIRE CERTAIN INORGANIC METALLIC CATIONS LIKE Mg, Mn, Zn, Ca, Co. Cu, etc., FOR THEIR OPTIMUM ACTIVITY.
  • 57. Metal activated enzymes  Metal activated enzymes are enzymes that have an increased activity due to the presence of metal ions. ... However, these ions are not tightly bound with the enzyme as in metalloenzymes. The metal can activate the substrate, thus engage directly with the activity of the enzyme.
  • 58.  Metalloenzymes are enzymes that contain a tightly bound metal ion.
  • 59. 7. EFFECT OF TIME UNDER IDEAL CONDITIONS (PH, TEMPERATURE) THE TIME REQUIRED FOR AN ENZYME REACTION IS LESS.
  • 60. 8.EFFECT OF LIGHT AND RADIATION  EXPOSURE OF ENZYMES TO UV, & X- RAYS INACTIVATES CERTAIN ENZYMES DUE TO FORMATION OF PEROXIDES. Eg; UV rays inhibit salivary amylase.
  • 61. ACTIVE SITE  DEFINITION: THE ACTIVE SITE OF AN ENZYME IS DEFINED AS THE SMALL REGION OF THE ENZYME WHERE SUBSTRATE BINDING AND CATALYSIS OCCURS IS REFFERED TO AS ACTIVE SITE.
  • 62.
  • 63. SALIENT FEATURES:-  The existence of active site is due to the tertiary structure of protein resulting in the three dimensional native conformation. Loss of native enzyme structure will result in derangement of active site.
  • 64.  Although all parts are required for keeping the exact three dimensional structure of the enzyme, the reaction taking place at active site. The active site occupies only a small portion of whole enzyme. Eg; lysozyme has 129 amino acids . The active site formed by 35,52,62,63& 101 amino acids.  Active sites are regulated as CLEFTS OR CERVICES occupying a small region in a big enzyme molecule.  Active site is FLEXIBLE not RIGID.
  • 65.  It possesses SUBSTRATE BINDING SITE & CATALYTIC SITE.  The substrate binds at active site by non- covalent bonds. There forces are hydrophobic in nature.  Enzyme specificity is due to active site.  The amino acids ser, asp., his, lys, arg, tyr, are repeatedly found at active site.
  • 66. ENZYME INHIBITION  An enzyme inhibitor is a molecule that binds to an enzyme and decreases its activity. By binding to enzymes' active sites, inhibitors reduce the compatibility of substrate and enzyme and this leads to the inhibition of Enzyme-Substrate complexes' formation, preventing the catalysis of reactions and decreasing (at times to zero) the amount of product produced by a reaction.
  • 67.  It can be said that as the concentration of enzyme inhibitors increases, the rate of enzyme activity decreases, and thus, the amount of product produced is inversely proportional to the concentration of inhibitor molecules. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. They are also used in pesticides.
  • 68.  Not all molecules that bind to enzymes are inhibitors; enzyme activators bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
  • 69. ENZYME INHIBITION  Enzyme inhibitor is defined as a substance which binds the enzyme and brings about a decrease in catalytic activity.  The inhibitor may be organic or inorganic in nature.  Enzyme inhibitor is a substance which binds with the enzyme and brings about a decrease in the catalytic activity of that enzyme
  • 70.  Three broad categories of enzyme inhibition. 1. Reversible inhibition 2. Irreversible inhibition 3. allosteric inhibition 1.REVERSIBLE INHIBITION The inhibitor binds non-covalently with enzyme and the enzyme inhibition can be reversed if the inhibitor is removed. Is further sub-divided into-
  • 71. i. competitive inhibition ii. Non- competitive inhibition iii. Un- competitive inhibition i. COMPETITIVE INHIBITION Here the inhibitor (I) closely resembles the normal substance (S) is regarded as SUBSTRATE ANALOHGUE.  As long as the inhibitor holds the active site, the enzyme is not available for the substrate to bind.
  • 72.  During the reaction , ES & EI complexes are formed. E + S ES E+P + I EI  Here the reaction velocity is decreased.  Excess substrate abolishes the inhibition.  Km is increased, Vmax unchanged.
  • 74. CLINICALLY USEFUL COMPETITIVE INHIBITORS DRUG ENZYME INHIBITED CLINICAL USE 1.Allopurinol 2.Dicoumarol 3.Pencillin 4.methotrexat e Xanthine oxidase Vit.K epoxide reductase Trans peptidase FH2- reductase Gout Anti-coagulant Bacteria cancer
  • 75. ii. NON-COMPETITIVE INHIBITION  The inhibitor binds at site other than active site.  This binding impairs enzyme function.  No structural resemblance with the substrate.  Km is unchanged, Vmax islowered.  Increase in substrate concentration can’t abolish non-competitive inhibition.
  • 76.  3D structure may abolish.  The inhibitor binds with enzyme as well as the ES complex. E + S ES E+P + + I I EI EIS  Heavy metal ions (Ag,Pb,Hg,etc.,) can non- competitively inhibit the enzyme.
  • 77.
  • 78. iii. UN-COMPETITIVE INHIBITION  The inhibitor doesn't binds with enzyme but only binds with ES complex.  Un-competitive inhibitor decreases both Km & Vmax . E + S ES E+P + I ESI
  • 79.  Inhibition of placental ALP by phenylalanine is an Eg. Of un-competitive inhibition.
  • 80. 2. IRREVERSIBLE INHIBITION  The inhibitors binds covalently with the enzymes and inactivate them.  These inhibitors are usually toxic substances. Eg: IODOACETATE is an irreversible inhibitor of papain & G3PDH. Iodoacetate combines with –SH groups at active site & inactivate the enzyme.
  • 81.  CYANID inhibits Cytochrome oxidase.  FLUORIDE removes MG & Mn ions & so inhibit enolase of glycolysis.  DI-ISOPROPYL FLUROPHOSPHATE(DFP) is a nerve gas developed by Germans during 2nd world war. It inhibits the enzymes containing Ser at the active site. Eg; serine protease, acetyl choline, esterase, ( which has imp. function in nerve transmission).
  • 82. SUICIDE INHIBITION  IT IS SPECIAL TYPE OF IRREVERSIBLE INHIBITION.  In this, the structural analogue is converted to a more effective inhibitor. Eg; 1. ALLOPURINOL which is oxidized by xanthine oxidase to ALLOXANTHIN that is a strong inhibitor of xanthin oxidase.
  • 83. 2. Ornithine difluro methyl decarboxilase ornithine (DFMO) Is a inhibitor of trypanosomiasis (sleeping sickness). 3. 5-flurouracil fluro deoxy uridylate used in chemotherapy.
  • 84. ENZYME SPECIFICITY  Specificity is a characteristic nature of the active site.  Enzymes are high specific in their action.  The occurrence of thousands of enzymes is due to specific nature of enzymes.  It is three types. 1. Stereospecificity 2. Reaction specificity 3. Substrate specificity.
  • 85. 1.Stereo or optical specificity  Stereoisomers are the compounds which have the same molecular formula , but differ in their structural configuration.  Human enzymes are specific for L-A.A’s & D-carbohydrates.  The enzymes act on one isomer. Eg; L-A.A oxidase & D-A.A oxidase acts on L&D-A.A’s.
  • 86.  Hexokinase acts on D-hexoses  Glucokinase acts on D-glucose.  Amylase acts on α-glycosidic linkages.
  • 87. 2.REACTION SPECIFICITY  The same substrate can undergo different types of reactions, each catalysed by specific enzyme.  Amino acids can undergo transamination, deamination, decarboxilation, etc,. A.A oxidase keto acid A.A decarboxilase amine
  • 88. 3. SUBSTRATE SPECIFICITY  It is divided into 3 types a. Absolute specificity b. relative specificity c. broad specificity.
  • 89. a. Absolute substrate specificity  Certain enzymes act only on one substrate. Eg; glucokinase glucose glucose-6-phosphate urease urea ammonia + co2
  • 90. b. Relative substrate specificity  Enzymes act on structurally related substances.  Its may depends on BOND or GROUP. Eg; trypsin hydrolyses peptide linkages involved in trp., lys.  CHYMOTRYPSIN cleaves phe, tyr, trp.  GLYCOSIDASES cleaves glycosidic bonds.
  • 91. c. Broad specificity  This enzymes act on closely related substances Eg; hexokinase acts on glucose. Fructose, mannose.
  • 92. COENZYMES  DEFINITION : the non-protein, organic, low mol.wt and dialysable substance associated with enzyme function is known as coenzyme.  Only protein part of enzyme can’t participate in catalytic activity.  Many enzymes require coenzymes for catalysis.
  • 93.  The cofactors may organic or inorganic in nature.  The functional enzyme is referred to as HOLOENZYME which is made up of a protein part APOENZYME and non-protein part COENZYME.  Coenzymes undergo alterations during enzyme reactions, which are later regenerated. This is in contrast to the substrate which is converted to the product.
  • 94.  Coenzymes participate in various reactions involving transfer of atoms or groups like hydrogen, aldehyd, keto, amino, acyl, methyl, etc.  Coenzymes play a imp. role in enzyme function.  The specificity of enzyme is mostly dependent on the apoenzyme and not on the coenzyme.  It is heat stable.
  • 95. CO-ENZYMES FROM B-COMPLEX VITAMINS:  Most of coenzymes are the derivatives of B-complex vitamins. Eg; TPP, FMN, FAD, NAD+, NADP+, PLP, CoA,
  • 96. NON-VITAMIN CO-ENZYMES :  Not all coenzymes are vitamin derivatives. There are some other organic substances, which no relation with vitamins. Eg; ATP, CDP, UDP, SAM, PAPS. NUCEOTIDE CO-ENZYMES :  Some enzymes possess nitrogenous base, sugar and phosphate. Such coenzymes are known as nucleotide coenzymes. eg; NAD+, NADP+, FMN, FAD, CoA.
  • 97. MECHANISM OF ENZYME ACTION  Catalysis is prime function of enzyme.  For any chemical reaction to occur, the reactants have to be in an activated or transition state.  There are few theories explaining the MEHANISM OF ACTION OF ENZYMES.
  • 98. Enzyme lower activation energy  Enzymes lower the energy of activation.  Activation energy is defined as the energy required to convert all molecules of a reacting substance from the ground state to the transition state.  The reactants when heated attain the activation energy.
  • 99.  Enzymes don't alter the equilibrium constant, they only enhance the velocity of the reaction.  The enzyme reduces the activation energy. Eg; activation energy needed for decomposition of H2O2 is 765KJ/mol. In the presence of platinum, it is 49KJ/mol.and in the presence of enzyme, the activation energy is <8KJ/mol.
  • 100. ENZYME SUBSTRATE COMPLEX FORMATION  The prime requisite for enzyme is that the substrate (S) must combine with the enzyme (E) at the active site to form enzyme- substrate complex (ES) which ultimately results in the production formation (P). E+S ES E+P
  • 101. LOCK & KEY MODEL or FISCHER’S TEMPLATE THEORY  It is the first model proposed to explain an enzyme catalysed reaction.  ACCORDING TO THIS MODEL, 1. Structural confirmation of enzyme is rigid 2. Active site is complementary to the substrate.  Which could not explain the flexibility shown by enzymes.
  • 102. INDUCED FIT THEORY or KOSHLAND’S MODEL  It is more acceptable and realistic model for ES complex formation.  AS PER THIS MODEL, – The active site is not rigid & pre-shaped. – Substrate binds to a specific part of the enzyme. – The substrate induces conformational changes in the enzyme.
  • 103.  Allosteric inhibition can also be explained by the hypothesis of koshland.  It has experimental evidence from the X-ray diffraction studies.
  • 104. SUBSTRATE STRAIN THEORY  In this model, the substrate is strained due to the induced confirmation change in the enzyme.  When substrate binds to the preformed active site, the enzyme induces a strain to the substrate.  The strained substrate leads to the product formation.  It explains the role of enzyme in increasing the rate of reaction.
  • 105. REGULATION OF ENZYME ACTIVITY – The Enzyme activity can be regulated by two means  Altering the activity of existing enzyme (fine control)  Altering the concentration of enzymes (coarse control)
  • 106. REGULATION OF ENZYME ACTIVITY- I –Allosteric regulation –Feed back inhibition –Regulation by covalent modifications –Activation of latent enzymes
  • 107. REGULATION OF ENZYME ACTIVITY- II  Induction and repression of enzyme synthesis others  Compartmentation of metabolic pathways.  Substrate concentration
  • 108. ALLOSTERIC REGULATION  Enzymes possess additional sites, known as allosteric sites such enzymes are known as allosteric enzymes  Allosteric modulators bind at the allosteric site regulate the enzyme activity.  Enzyme activity increased when a +ve allosteric effector binds at the allosteric site  Enzyme activity maybe decreased when a –ve allosteric effector binds at the allosteric site
  • 109. CLASSES OF ALLOSTERIC ENZYMES Depending on Vmax and Km K-Class of Enzymes V-Class of Enzymes Changes Km and not Vmax Changes Vmax and not Km Similar to competitive group Non-competitive group PFK involvedin glycolytic pathway Acetyl-COA carboxylase involvedin fatty acid synthesis
  • 110. MECHANISM OF ALLOSTERIC REGULATION  Most of allosteric enzymes are oligomers  Subunits may be identical or different  Effector binds non-covalently to a site other than the active site and this regulatory site may be located on a subunit that it self may not be catalytic subunit  A conformational change occurs in the active site of the enzyme leading either to activate or inhibition of the enzyme depending on the type of effector  Accordingly allosteric enzymes in the conformational states that T (Tense or Taut) and the R (Relaxed) - T form low affinity form for substrate - R form high affinity form for substrate  So inhibitor favors T form and activator favors R form
  • 111. TYPE OF EFFECTOR HOMOTROPIC EFFECTOR  When the substrate itself serves as an effector it is called as homotropic effector  That is the substrate influences the substrate binding though allosteric mechanism.  Their effective is always positive.  These enzymes show a sigmoidal curve when velocity is plotted against substrate concentration. This contrasts with the hyperbolic curve charcteristic of enzymes which follow Michaelis-Menten equation
  • 112. HETEROTROPHIC EFFECTER • When the effecter is different from the substrate that is called Heterotrophic effecter  Heterotrophic interactions are either +ve or -ve.
  • 113. ENZYMES WITH ALLOSTERIC EFFECTORS  Features of allosteric inhibition – Inhibition not a substrate analogue – Partially reversible when excess substrate added – Km is usually increased – Vmax is usually decreased – Most allosteric enzymes possess quaternary structure .
  • 114.
  • 115. ENZYMES WITH ALLOSTERIC EFFECTORS Enzyme Metabolic pathway Inhibitor Allosteric Activator Hexokinase Glycolysis Glucose6- Po4 - Phosphfruct okinase Glycolysis ATP AMP,ADP Pyruvate carboxylase Glucooneogeonesis _ Acetyl CoA Acetyl CoA carboxylase Fatty acid synthesis Palmitate Isocitrate
  • 116. FEED BACK INHIBITION  process of inhibiting the first step by the final product in a series of enzyme catalyzed reaction of a metabolic pathway is referred to as feed back inhibition  A e1 B e2 C e3 D e4 E  Initial substrate Final substrate
  • 117. FEED BACK INHIBITION OF METABOLIC PATHWAY
  • 118.  When the final product E inhibits the first step it is called as feed back regulation/ negative feed back regulation because the product E ultimately stops its own synthesis  This is an effective mechanism because, it saves the energy expenditure involved in the synthesis of a compound which is already available with in the cell E.g. 1. Aspartate trans carbamoylase (ATCase) (pyrimidine metbolism)-CTP inhibits ATCase 2. HMG-COA reductase(Cholesterol biosynthesis)
  • 119. REGULATION BY COVALENT MODIFICATION  Many enzymes exists in the active and inactive form which are intercovertible depending upon the needs of the body  Covalent modification is the change in the activity of the enzyme by either adding a group to enzyme protein by covalent bond or removing a group by cleaving a covalent bond.  Includes, 1. Phosphorylation and dephosphorylation 2. Adenylation and deAdeylation 3. ADP ribosylation,Uridylation ,Methylation
  • 120. • Control of phosphorylation and dephosphorylation is mainly exhibited by the hormones like (epinephrine, thyroxine etc) and an enzyme may be active in the phosphorylated state or dephosphorelated state
  • 121.  E.g. Glycogen phosphorylase an enzyme involved in cleavage of glycogen to provide glucose or energy  Phosphorylase exists in the forms A B dePhosphorylated form phosphorylated form inactive form active form
  • 122.  Like wise some enzymes are active in the deposphorylated state and become inactive when phosphorylated  E.g. Glycogen synthase, Acetyl coa carboxylase
  • 123. ACTIVATION OF LATENT ENZYMES  Some enzymes exists in latent forms and latent forms as such are inactive for Eg enzymes may be synthesized as proenzymes or zymogens which undergo irreversible covalent activation by the breakdown of one or more peptide bonds  E.g. chymotripsinogen, trypsinogen, and plasminogen are respectively converted to chymotrypsin, trypsin and plasmin
  • 124. COARSE CONTROL  Modification in the concentration of the enzyme this is done by regulating the rate of enzyme synthesis that is Induction and repression of enzyme synthesis  Induction – Increased synthesis of the enzyme  Repression – Decreased synthesis of the enzyme  This is coordinated at the level of gene and is also mediated mainly through the hormones
  • 125. COARSE CONTROL  E.g. Hormone insulin induces the enzyme involved in the utilization of glucose  1. Glucokinase  2. Phospho fructokinase  3. Pyruvate kinase  Like wise insulin represses enzyme involved in glucose synthesis (gluconeogenesis) like Glucose-6phosphatase  ,fructose-1,6biphosphatase
  • 126. COMPARTMENTATION OF METABOLIC PATHWAYS  Certain substances in the body are both synthesized and also degraded in the body and there is no point for simultaneous occurrence of both  So this can be regulated by compartmentation that is synthesis pathway occurs in one organelle and breakdown pathway occurs in other organelle  E.g. fatty acid synthesis take place in cytoplasm, fatty acid degradation take place in mitochondria, more over enzymes of the same pathway may be present in cytoplasm and mitochondria
  • 127.  Some may be present only in cytoplasm and some only in mitochondria  Eg Heme synthesis Urea cycle Gluconeogenesis For all the these pathways some Enzyme may be located In cytoplasm some may be in mitochondria and so the intermediates have to be Shuttled across the mitochondrial membrane. This provides a point where again control can be exerted
  • 130. CLINICAL APPLICATION OF ENZYMES  Enzymes are present in all the tissues  It is having different applications clinically 1. Diagnosing a disease 2. To diagnose a congenital disorder 3. Measurement of compounds 4. As therapeutic agents 5. Enzymes linked to insoluble materials are used as chemical reactors. 6. Most of the drugs are acting by inhibiting the enzymes
  • 131. IN DIAGNOSIS OF DISEASE
  • 132. Enzyme Tissue affected Amylase Pancreas Lipase Pancreas AST Cardiac , hepatic ALT Hepatic inflammation ALP Hepatic obstruction, bone GGT Hepatic damage Creatinine kinase Brain, cardiac / skeletal Ck- MB Necrosed cardiac tissue Acid phosphatase Prostate LDH Cellular lysis,non- specific
  • 133. ENZYMES IN DIAGNOSIS Functional Non- functional Specific to plasma Have definite function Present in high concentration Enters plasma from tissues No function in plasma Normally the level will be low These non- functional enzymes are more important for clinician to diagnose a disease
  • 134. ENTRY OF TISSUE ENZYMES INTO PLASMA They enter  when disease process cause changes in cell membrane permeability  When cell dies  Since there is gross difference between intracellular and extra cellular concentration
  • 135. PATTERN OF ENTRY OF ENZYMES  Greater the tissue damage larger will be the concentration of enzymes in plasma  Cytosolic enzymes will appear before mitochondrial enzymes
  • 136. ENZYME LEVELS IN PLASMA  The levels are maintained by the following factors 1. Rate of release of enzymes into plasma 2. Stability of enzymes in plasma 3. The clearance rate of enzymes by reticulo - endothelial system (Half –life)
  • 137. WHAT AN ENZYME DOES E+S ES EP E+P  The enzyme (E) binds substrate (S) and converts it to product (P).  Note that E recycles.  Overall, S P
  • 138. MEASUREMENT OF ENZYME CK CrP + ATP creatine + ADP pH 9.0 PK ADP+ phosphoenol pyruvate ATP+ pyruvate LD Pyruvate + NADH +H Lactate+ NAD The change in absorbance produced in this reaction is a measure of enzyme activity
  • 139. WE CALL THIS MEASUREMENT AN ENZYME ASSAY.  Decrease in substrate or  Increase in product  Typically change in absorbance 0 30 s 1 min 2 min 4 min 8 min
  • 140. INCREASE SUBSTRATE CONCENTRATION 2 1 3 4 5 6 7 8 0 Product 80 60 40 20 0 S + E ↓ P ( in a fixed period of time ) 0 2 4 6 8 Substrate (mmole)
  • 141. HOW WE MEASURE ENZYME ACTIVITY  Choose best conditions. All these variables affect reaction. – Temperature – pH – enzyme concentration – substrate concentration – co-factors – Inhibitors  Keep everything constant except one variable, and study that.
  • 142. ENZYME ACTIVITY OFTEN MEASURED AS COLOUR CHANGE Time Absorbance S P Increase in absorbance over time is not linear. This is because of back- reaction (or sometimes the product inhibits).
  • 143. ENZYME ACTIVITY OFTEN MEASURED AS COLOUR CHANGE Time Always measure INITIAL rate Express this as DA/time (vo). A b s o r b a n c e
  • 144. © 2007 Chettinad Hospital & Research Institute -4 -2 0 2 4 1/[S] 0 1 2 [S] no 1 2 3 4 0.25 0.50 1.0 2.0 0.42 0.72 0.80 0.92 Absorbance v (mmole/min) [S] 0.21 0.36 0.40 0.46 (1) The product was measured by spectroscopy at 600 nm for 0.05 per mmole (2) Reaction time was 10 min 1/S 1/v 4 2 1 0.5 2.08 1.56 1.35 1.16 → → → → v Direct plot Double reciprocal 2.0 1.0 0 1/v 1.0 -3.8 no 1 2 3 4 0.25 0.50 1.0 2.0 0.42 0.72 0.80 0.92 Absorbance v (mmole/min) [S] 0.21 0.36 0.40 0.46 1/S 1/v 4 2 1 0.5 2.08 1.56 1.35 1.16 → → → → 1.0 0.5 0 v 2.0 1.0 0 1/v 1.0 -3.8 Data Velocity Substrate Product Double reciprocal A REAL EXAMPLE FOR ENZYME KINETICS
  • 145. ENZYMES PATTERNS (ENZYME PROFILES) IN DISEASES © 2007 Chettinad Hospital & Research Institute Hepatic Disease 1. Alanine Amino Transferase (ALT) Marked Increase in parenchymal liver disease 2. Nucleotide phosphatse (NTP) Elevated in liver dysfuntion with cholestasis 3. Alkaline phosphatse (ALP) Marked increase in obstructive Liver disease 4. Gamma Glutamyl transferase Increase in obstructive and alcoholic liver disease
  • 146. Myocardial Infarction 1. Creatine Kinase First enzyme to rise followin infarction, CK-MB iso-enzyme is specific 2. Aspartate Amino Transferase rise after the rise of CK and return to normal in 4 - 5 days 3. Lactate Dehydrogenase Last enxyme to rise. LDH-1 becomes more than 2 (Flipped Pattern) (ENZYME PROFILES) IN DISEASES CONT Bone Disease Alkaline Phosphates Marked Elevation in Osteoblastic bone activity as in rickets. Labile bone isoenzyme is elevated. Also in paget’s Disease
  • 147. (Enzyme profiles) in diseases cont Muscle Disease 1. Creatine Kinase (CK - MM) Marked increase in Muscle Disease. CK - MM fraction is elevated. 2. Aspartate amino Transferase (AST) Shows an increase in different types of muscle disease; not specific 3. Aldolase (ALD) Earliest enzyme to rise, but not specific Prostate Cancer 1. Prostatic Specific Antigen Marker for Prostate Cancer. Mild increase in benign prostate enlargement 2. Acid Phosphatase Marker for Prostate Cancer. Metastatic bone disease especially from a Primary from prostate. Inhibited by L tartrate.
  • 148. CLINICAL SIGNIFICANCE OF ISO-ENZYMES Separation of Iso-Enzymes by 1. Heat stability 2. Gel Electrophoresis 3. Immuno Elctrophoresis 4. Lectin Binding Assay 5. Monoclonal Antibodies
  • 149. CREATININE KINASE – TOTAL •Death of cardiac tissue •Skeletal Muscle Injury •Brain Disorders •To Distinguish CK – MB, CK-MM and CK – BB can be done. •If any one increase Total Will increase
  • 150. CREATININE KINASE ISOENZYMES PATTERNS Tissue CK1 BB CK2 MB CK3 MM Brain 97.3 2.7 0 Heart 1.3 20 78.7 Skeletal Muscle 0.06 1.1 98.9
  • 151. INCREASE IN CK - TOTAL • Myocardial Infarction • Severe muscle disorder • Myopathies • Fertiliser Poisoning (Organo Phosphorus Compounds) • Brain injuries, surgeries.
  • 152. ALKALINE PHOSPHATASE (ALP) • Liver – 50 % • Bone – 50 % • Kidney • Small Intestine • Placenta
  • 153. Algorhythm Sole Elevation of ALP Age of the patient (Childhood & Adolescence) High due to bony growth No need to proceed No need to proceed Pregnant No need to proceed Do Liver Enzyme Gamma GT / 5 Nucleotidase Normal Do the Heat Stability Test High No need to proceed
  • 154. HOW TO INTERPET? if there is abnormal ALP. •In moderate increase see the age and sex of patient. If the patient is in growth spurt then it is physiological increase due to bony growth (Osteoblastic Action) •If the patient is Female and pregnant then the increase may be due to release from placenta •If it is due to Liver other enzymes pertaining to it can be measured if normal ------ rule out liver disorder
  • 155. •Do the heat stability test --- Liver fraction denatures but bony fraction is stable to heat. So if the levels are still high after heating it at 57c then the enzymes may be of bony origin (It will increase in bony cancer (or) fracture but the increase occurs in osteoblastic conditions •If Measurement is done after heavy fat meal then mild increase in ALP may be noticed due to origin from small intestine.
  • 156. ESTIMATION OF CERTAIN COMPOUNDS (EG., GLUCOSE, CHOLESTEROL) •Earlier 2 decades ago Glucose is estimated based on their chemical property ,reducing activity of sugars. But there are other reducing agents which may come and interfere. • Hence now a days Glucose is measured by Glucose Oxidase enzyme. Here the enzyme is so specific and we may get true value of Glucose in Plasma.
  • 157. Enzyme Used for testing Urease Uricase Glucose Oxidase Peroxidase Hexokinase Cholesterol Oxidase Lipase Horse Radish Peroxidase Alkaline Phosphatase Restriction Endonuclease Reverse Transcriptase Urea Uric Acid Glucose Glucose; Cholesterol Glucose Cholesterol Triglycerides ELISA ELISA Southern blot; RFLP Polymerase Chain Reaction ENZYMES USED FOR DIAGNOSTIC PURPOSE
  • 158. PRINCIPLE OF CHOLESTEROL ESTIMATION Cholesterol Oxidase Cholesterol + O2 H2O2 + Cholest - 4 en- 3 one Peroxidase H2O2 H2O +O O + Colorless Dye colored Dye which is measured at particular wavelength and it is directly proportional to cholesterol level in blood Simple Machines which can give you the results with in few minutes.
  • 159. ELIZA • In the modern Clinical Chemistry  ELIZA Plays an important role. • Especially when we have to measure which are present in nano grams E.g. Hormonal Assay and Assay of Proteins present in very low concentration • It is Based on the Principle that Antigen is captured by the specific monoclonal • Antibody which are tagged by enzymes and its subsequent reaction with substrate in negligible amounts. • (Beneficial effect from the wedding of enzyme chemistry am Immunology)
  • 160. Enzyme Immuno Assay to Detect or Measure Antibody In a Patients Serum
  • 161. Enzyme Immuno Assay to detect an antigen . E.g. Hepatitis B Surface Ag HBsAg
  • 162. TO CONFIRM THE DIAGNOSIS OF THE CONGENITAL METABOLIC DISORDERS They are often due to deficiency of enzymes of one (or) other metabolic pathway 1.Glucose 6 Phosphatase Von-Gierke’s disease 2.Glucose 6 phosphate dehydrogenase (G6PD)  Hemolytic Anemia Identification of deficient enzyme confirms the diagnosis and gene therapy may help to over come the hurdles in future.
  • 163. ENZYMES AS THERAPEUTIC AGENTS •Strepto kinase prepared from streptococcus •Tissue Plasminogen activator (t PA) bioengineered in E- Coli Helps in dissolving the blood clots leading to myocardial infarction. They convert the pro-enzyme plasminogen to plasmin, which cleaves the insoluble fibrin in to soluble components.
  • 164. ENZYMES AS THERAPEUTIC AGENTS - CONT • The Concentration of Enzyme needed for therapeutic achievement should be high Since it is rapidly cleaved by Reticulo Endothelial System. • This difficulty will be overcome in future, because the work is now going on to couple enzyme to solid matrices and they are implanted in highly perfused area
  • 165. Enzyme Therapeutic Application Asparginase Streptokinase Urokinase Streptodornase Hyaluronidase Pancreatin(Trypsin and Lipase) Papain Alpha 1 – Antitrypsin Acute Lymphoblastic Leukemia To lyse Intravascular Clot Do DNAse; applied locally Enhances Local Anaesthetics Pancreatic Insufficiency; oral administration Anti-Inflammatory AAT Deficieny; Emphysema EXAMPLES OF THERAPEUTIC USE OF ENZYMES

Editor's Notes

  1. 144
  2. 145
  3. 147
  4. 148
  5. 149
  6. 150
  7. 151
  8. 152
  9. 153
  10. 154
  11. 156
  12. 157
  13. 158
  14. 159
  15. 160
  16. 161
  17. 162
  18. 163
  19. 164
  20. 165